BIOM Pharmaceutical
Pre-clinicalDevelops novel small molecule therapeutics targeting oncology and inflammatory diseases through innovative drug discovery platforms.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $9.9M
About
Develops novel small molecule therapeutics targeting oncology and inflammatory diseases through innovative drug discovery platforms.
Microbiome
Funding History
17Total raised:$9.9M
Grant$198KSep 12, 2019
Grant$1MAug 19, 2015
Grant$1MAug 14, 2014
Grant$202KJul 15, 2014